Baca berita tanpa iklan. Gabung Kompas.com+
Tentukan Pilihanmu
0 hari menuju
Pemilu 2024
June 29, 2021, 02.45 AM


JAKARTA, KOMPAS.com – Indonesia might get a break in its uphill struggle against Covid-19, after Indonesian officials highlighted the use of the anti-parasite drug Ivermectin as a potential treatment for the coronavirus.

Presidential Chief of Staff Moeldoko are among the leading proponents of the medication, as based on its successful use in 33 countries.

“According to the Front Line Covid-19 Critical Care [FLCCC] Alliance [NGO], countries like Brazil, Japan and India have effectively used Ivermectin to overcome their Covid-19 crisis,” said the former Indonesian Armed Forces commander.

Also read: Indonesian Medical Association Urges Govt. to Close Borders Temporarily Over Covid Variants  

“The use of he Covid-19 pandemic in Indonesia is currently at a critical phase, as the number of cases from the new Delta strain of the coronavirus increased. This is reflected by rising bed occupancy rates [BOR] in Covid-19 emergency hospitals around the country.”

He added that the dire situation from the pandemic entailed finding out-of-the box solutions, among them the use of Ivermectin to treat Covid-19.

Doses of IvermectinShutterstock Doses of Ivermectin

An American Journal of Therapeutics study involving 3,406 volunteers in 15 clinical groups have found that Ivermectin has a 95 percent effectiveness rate in treating Covid-19.

The British Ivermectin Recommendation Development (BIRD) Group research of 24 clinical tests in 15 countries, among them Peru, Mexico, to Slovakia is just as promising, as it was shown to reduce the number of deaths among Covid-19 cases.

Data from the Indonesian Farmers Association or HKTI, which is chaired by Moeldoko, also showed that Ivermectin can reduce Covid-19 case numbers in Jakarta, Tangerang, Depok and other cities in Indonesia by nearly 100 percent.

Also read: Indonesian Doctors Association: Covid-19 Killed Over 700 Medical Personnel

Baca berita tanpa iklan. Gabung Kompas.com+
Page:


Baca berita tanpa iklan. Gabung Kompas.com+
Comment wisely and responsibly. Comments are entirely the responsibility of the commentator as regulated in the ITE Law
Report
Thank You! We have received your report. We will remove comments that conflict with the Community Guidelines and the ITE Law.

More Headlines

Baca berita tanpa iklan. Gabung Kompas.com+
Baca berita tanpa iklan. Gabung Kompas.com+
Baca berita tanpa iklan. Gabung Kompas.com+
Baca berita tanpa iklan. Gabung Kompas.com+
Close Ads
Oke
Baca berita tanpa iklan. Gabung Kompas.com+